Citation only
via OpenAlex
Problems of cell death in neurodegeneration and Alzheimer's Disease
K. A. Jellinger, Christine Stadelmann
Journal of Alzheimer s Disease · 2001 · ▲ 96 citations
Abstract
Progressive cell loss in specific neuronal populations is a pathological hallmark of neurodegenerative diseases, but its mechanisms remain unresolved. Apoptosis or alternative pathways of neuronal death have been discussed in Alzheimer disease (AD) and other disorders. However, DNA fragmentation in human brain as a sign of neuronal injury is too frequent to account for the continuous loss in these slowly progressive diseases. In autopsy cases of AD, Parkinson's disease (PD), related disorders, and age-matched controls, DNA fragmentation using the TUNEL method and an array of apoptosis-related proteins (ARP), proto-oncogenes, and activated caspase 3, the key enzyme of late-stage apoptosis, were examined. In AD, a considerable number of hippocampal neurons and glial cells showed DNA fragmentation with a 3- to 6-fold increase related to amyloid deposits and neurofibrillary tangles, but only one in 2.600 to 5.650 neurons displayed apoptotic morphology and cytoplasmic immunoreactivity for activated caspase~3, whereas no neurons were labeled in age-matched controls. Caspase~3 immunoreactivity was seen in granules of cells with granulovacuolar degeneration, in around 25% In progressive supranuclear palsy, only single neurons but oligodendrocytes in brainstem, around 25% TUNEL-positive and expressed both ARPs and activated caspase 3. In PD, dementia with Lewy bodies, and multisystem atrophy (MSA), TUNEL-positivity and expression of ARPs or activated caspase~3 were only seen in microglia and oligodendrocytes with cytoplasmic inclusions in MSA, but not in neurons. These data provide evidence for extremely rare apoptotic neuronal death in AD and PSP compatible with the progression of neuronal degeneration in these chronic diseases. Apoptosis mainly involves reactive microglia and oligodendroglia, the latter occasionally involved by deposits of insoluble fibrillary proteins, while alternative mechanisms of neuronal death may occur. Susceptible cell populations in a proapoptotic environment, particularly in AD, show increased vulnerability towards metabolic or other noxious factors, with autophagy(definition) as a possible protective mechanism in early stages of programmed cell death. The intracellular cascade leading to cell death still awaits elucidation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3233/jad-2001-3106
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Jellinger, K.A., & Stadelmann, C. (2001). Problems of cell death in neurodegeneration and Alzheimer's Disease. <em>Journal of Alzheimer s Disease</em>. https://doi.org/10.3233/jad-2001-3106
Vancouver
Jellinger KA, Stadelmann C. Problems of cell death in neurodegeneration and Alzheimer's Disease. Journal of Alzheimer s Disease. 2001. doi:10.3233/jad-2001-3106.
BibTeX
@article{k2001Proble,
title = {Problems of cell death in neurodegeneration and Alzheimer's Disease},
author = {K. A. Jellinger and Christine Stadelmann},
journal = {Journal of Alzheimer s Disease},
year = {2001},
doi = {10.3233/jad-2001-3106},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2007
Open access · CC-BY
Identification of Novel High-Frequency DNA Methylation Changes in Breast Cancer
Biomolecules 2024
Open access · CC-BY
Mitophagy in Cell Death Regulation: Insights into Mechanisms and Disease Implications
Antioxidants 2021
Open access · CC-BY
Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery
European Journal of Heart Failure 2009
Open access · OA
The Nobel Prize for Medicine for Telomere Biology and Relevance to Heart Failure Research
PLoS ONE 2011
Open access · CC-BY
α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients
BMB Reports 2017
Open access · CC-BY